The tiny Miami biotech spent years testing a simple idea: digest inflammatory RNA instead of suppressing the immune system. Its first big readouts were messy - and the useful part was hiding inside the miss.
Mirvie is a South San Francisco biotech using cell-free RNA signatures and machine learning to predict pregnancy complications - preeclampsia, preterm birth, fetal growth restriction - months before symptoms appear. Its flagship product Encompass is a blood test built on a foundational study of nearly 11,000 pregnancies.